Company intelligence / Profile preview
AstraZeneca
Cambridge, Cambridgeshire, UKazdelta.be ↗
- Ownership
- Public · AZN
- Employees
- ~80000
- Development stage
- Commercial
01
Overview
AstraZeneca is one of the world’s largest biopharmaceutical companies with a diverse portfolio of marketed products and an industry-leading clinical pipeline. Its key marketed drugs include Tagrisso (osimertinib) for non-small cell lung cancer; Farxiga (dapagliflozin) for type II diabetes and heart failure; Crestor (rosuvastatin) for high cholesterol; Symbicort (budesonide/formoterol) for asthma/COPD; Nexium/Prilosec for GERD. The company is advancing new therapies in oncology—including antibody-drug conjugates and bispecific antibodies—metabolic disease/obesity treatments such as oral GLP‑1 modulators and amylin agonists in early-stage trials. It also played a leading role in COVID‑19 vaccine development
- Therapeutic areas
- Rare DiseasesOncologyPulmonologyCardiovascular
- Modalities
- Small moleculeMonoclonal antibodyAntibody-drug conjugateBiologicVaccineRNA therapy
- Industry
- Pharma
02
Drug pipeline
583 assets582 more assets in the full pipeline.
Request access →03
Partnerships
Daiichi Sankyo (“Enhertu” ADC collaboration)Merck/MSD (“Lynparza” co-development)Ionis Pharmaceuticals (“eplontersen”)Moderna (“COVID‑19 vaccine”)Eccogene (“AZD5004” licensing)
04
Financials
- Market cap
- $248.2B
- Total revenue
- $15.4B
- Enterprise value
- $275.4B
Beyond the preview
Go deeper on AstraZeneca.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on AstraZeneca.